Skip to main content
Skip to footer
Dicerna Pharmaceuticals
Dicerna
Careers at Dicerna
News
Contact
Search for:
Our
Company
Management Team
Board of
Directors
Collaborating
Intellectual Property
Grants & Charitable Donations
Our GalXC™ Technology
Scientific Publications
Pipeline
Nedosiran (formerly DCR-PHXC)
RG6346 (formerly DCR-HBVS)
DCR-A1AT
Collaborative Programs
Clinical Trials
Patients
A Message To Our Patients
Patient Advocacy Charter
Primary Hyperoxaluria (PH)
Hepatitis B Virus
Alpha-1 Antitrypsin Deficiency-associated Liver Disease
Investors & Media
Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Information
Investor FAQs
Contact
Application Form
Our
Company
Grants & Charitable Donations
Application Form
Share this page:
Notice: JavaScript is required for this content.
Sign Up for Email Alerts
Our
Company
Management Team
Board of
Directors
Collaborating
Intellectual Property
Grants & Charitable Donations
Our GalXC™ Technology
Scientific Publications
Pipeline
Nedosiran
(DCR-PHXC)
RG6346 (formerly DCR-HBVS)
DCR-A1AT
Collaborative Programs
Clinical Trials
Patients
A Message To Our Patients
Patient Advocacy Charter
Primary Hyperoxaluria (PH)
Hepatitis B Virus
Alpha-1 Antitrypsin Deficiency-associated Liver Disease
Investors & Media
Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Information
Investor FAQs
Contact
Careers at Dicerna
News
Contact
Close
Cookies Policy
This site uses cookies as described in our Cookies Policy. To learn more about cookies, including how to disable them, view our
Cookies Policy
.
Click here to accept these terms.